Filters
Also try searching for:
PTI*
on 31 Jan 2024
H. LUNDBECK A/S
2308042 · 23 Nov 2023
009
Class 009
Computer & Software Products & Electrical & Scientific Products
Electronic publications (downloadable), including books, reports, brochures, booklets, magazines, including leaflets, magazines, journals, teaching and training material in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; computer software, recorded, including software for medical and pharmaceutical information, training and sales activities; software for websites, intranets and the Internet; downloadable software in the form of downloadable virtual goods authenticated by NFTs (non-fungible tokens), namely virtual pharmaceutical preparations and substances, including for use in online environments, virtual environments, augmented virtual reality environments and metaverses; downloadable software for use in digital advice; downloadable software for use in digital advice via apps; downloadable digital files authenticated by NFTs (non-fungible tokens); downloadable software for preparing, managing, storing, making available, sending, receiving, exchanging, validating and selling virtual pharmaceutical preparations and substances.
035
Class 035
Advertising, Business & Retail Services
Wholesale and retail trade in pharmaceuticals; advertising agency services in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; provision of the aforementioned services online, via cable or Internet or other electronic media; online retailing of digital files as well as virtual goods in the form of pharmaceutical preparations and substances, including goods and files authenticated by NFTs (non-fungible tokens); providing an online marketplace for buyers and sellers of digital files and virtual goods in the form of pharmaceutical preparations and substances, including goods and files authenticated by NFTs (non-fungible tokens).
Electronic publications (downloadable), including books, reports, broc...
on 26 Jul 2024
GLAXO GROUP LIMITED
2232158 · 13 Dec 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
on 26 Jul 2024
GLAXO GROUP LIMITED
2235629 · 13 Dec 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
on 17 May 2024
IDEXX LABORATORIES INC.
2215682 · 06 Sep 2022
001
Class 001
Chemical Products
Diagnostic reagents for medical laboratory use for testing bodily fluids for use with blood gas and electrolyte analyzers and for use in disease detection, namely, detection of viruses.
005
Class 005
Pharmaceutical Products
Diagnostic test kits comprised of diagnostic reagents and assays for testing bodily fluids for use with blood gas and electrolyte analyzers and for use in disease detection, namely, detection of viruses.
Diagnostic reagents for medical laboratory use for testing bodily flui...
on 05 Jul 2024
VARAD MEHTA
2174372 · 23 Mar 2022
029
Class 029
Meats and Processed Food Products
Canned fruits and vegetables; dried mushrooms; fruit preserves; jellies and jams; mushrooms, preserved; pickled fruits; pickled vegetables; pickles; pre-packaged dinners consisting primarily of meat; pre-packaged dinners consisting primarily of poultry; pre-packaged dinners consisting primarily of seafood; prepared meals consisting primarily of fruit; prepared meals primarily consisting of cooked fruits and vegetables
030
Class 030
Staple Food Products
Baking spices; barbecue sauce; brown sauce; chili sauce; dressings for salad; fish sauce; food seasonings; fruit sauce; gravy sauce; hot sauce; ketchup; ketchup sauce; pasta sauce; pepper sauce; pizza sauce; salad dressings; seasoning mixes; soy sauce; spices; stir fry sauces; sweet and sour sauce; teriyaki sauce
...
Class 031
Natural Agricultural Products
Fresh edible mushrooms; fresh fruit and vegetables; unprocessed mushrooms
Class 032
Light Beverage Products
Aerated fruit juice; aerated water; fruit drinks and fruit juices; fruit-based drinks; fruit-flavored beverages; non-alcoholic beverages containing fruit juices
Class 035
Advertising, Business & Retail Services
Online and retail sale of non-alcoholic beverages; online retail sale of food; retail sale of food
Canned fruits and vegetables; dried mushrooms; fruit preserves; jellie...
on 07 Sep 2022
H. LUNDBECK A/S
2046755 · 19 May 2020
005
Class 005
Pharmaceutical Products
Vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents
Vaccines for humans; pharmaceutical preparations and substances for th...
on 07 Sep 2022
H. LUNDBECK A/S
2044034 · 19 May 2020
005
Class 005
Pharmaceutical Products
Vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents
Vaccines for humans; pharmaceutical preparations and substances for th...
on 01 Jun 2022
H. LUNDBECK A/S
2024205 · 01 Apr 2020
010
Class 010
Medical Instrument Products
Surgical and medical apparatus and instruments, namely, knives for surgical use, lasers for surgical and medical use, medical and surgical catheters, medical and surgical laparoscopes, surgical clamps, surgical drills, surgical instruments, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes; medical devices, namely, syringes and pumps for administering drugs, syringes and needles for injections and for medical purposes; apparatus and instruments, namely, test kits for testing neurological diseases, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency for diagnostic purposes; integrated medical systems containing medical apparatus, namely drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes, and software for information storage, information management, and for accessing information in the fields of neurology, neurological diseases and disorders, and brain diseases and disorders for use in Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments, namely, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes for information, guidance, management and control of medicines
Surgical and medical apparatus and instruments, namely, knives for sur...
on 15 Jun 2022
H. LUNDBECK A/S
2043947 · 25 Feb 2020
005
Class 005
Pharmaceutical Products
Vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents
Vaccines for humans; pharmaceutical preparations and substances for th...
on 22 Dec 2021
GLAXO GROUP LIMITED
1998264 · 02 Oct 2019
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely, acid reflux and gastroesophageal reflux disease; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor and menopausal symptoms, endometriosis and uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy; Vaccines for human use.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
H. lundbeck a/s (8)
Glaxo group limited (5)
Merck sharp & dohme corp. (2)
Nino aktiengesellschaft (2)
Syngenta limited (2)
Agrosoft a/s (1)
Bristol-myers squibb company (a delaware corporation) (1)
Civeo canada inc. (1)
Dell inc. (1)
Epsilon polyolefin corporation (a new jersey corporation) (1)
Henkel ag & co. kgaa (1)
Hoffmann-la roche limited/hoffmann-la roche limitée (1)
Idexx laboratories inc. (1)
J. & p. coats limited (1)
Loop tackle design ab (1)
Oil states international inc. (1)
Opti-copy inc. (a delaware corporation) (1)
Optimize technologies inc. an oregon corporation (1)
Optirtc inc. (1)
P.T. international llc (1)
Pacific tradeline inc. (1)
Paion uk limited (1)
Plum traders inc. (1)
Syngenta participations ag schwarzwaldallee 215 basel ch (1)
Trupti enterprises inc. (1)
Twin laboratories inc. (a utah corporation) (1)
United grain growers limited operating as agricore united (1)
Varad mehta (1)
Wisconsin knife works (a wisconsin corporation) (1)
Categories
Class 5 (23)
Class 35 (7)
Class 9 (6)
Class 42 (5)
Class 7 (3)
Class 25 (3)
Class 29 (3)
Class 31 (3)
Class 40 (3)
Class 1 (2)
Class 3 (2)
Class 4 (2)
Class 10 (2)
Class 30 (2)
Class 37 (2)
Class 43 (2)
Class 8 (1)
Class 11 (1)
Class 14 (1)
Class 17 (1)
Class 18 (1)
Class 21 (1)
Class 26 (1)
Class 28 (1)
Class 32 (1)
Class 36 (1)
Class 38 (1)
Class 44 (1)
Class 45 (1)
Correspondents
Smart & biggar lp (12)
Gowling wlg (canada) llp (6)
Borden ladner gervais llp (4)
Dentons canada llp (2)
Norton rose fulbright canada llp/s.E.N.C.R.L.,s.R.L. (2)
Furman ip law & strategy pc (1)
John h. simpson (1)
Lapointe rosenstein marchand melançon, l.L.P./s.E.N.C.R.L. (1)
Mcmillan llp (1)
Osler, hoskin & harcourt llp (1)
Perley-robertson, hill & mcdougall llp (1)
Pitblado llp (1)
William l. northcote (1)
Image Search
Drag and drop or upload to search any image